|
Abstract:
|
In this presentation, different sources of safety and efficacy data will be briefly reviewed and selected statistical strategies and methods for analyzing safety data from various stages of drug development, post-marketing safety surveillance, and real world will be presented. Additionally, designs and strategies on how to use historical and published information to generate evidence for pediatric trials will be discussed.
|
